Full-Time

Director – Commercial Field Training

Heme

Confirmed live in the last 24 hours

Vertex Pharmaceuticals

Vertex Pharmaceuticals

1,001-5,000 employees

Develops medicines for serious diseases

Compensation Overview

$191.7k - $287.6k/yr

+ Bonus + Equity Awards

Senior, Expert

Company Does Not Provide H1B Sponsorship

Boston, MA, USA

Hybrid-Eligible: work remotely up to two days per week; or work five days per week on-site with ad hoc flexibility.

Category
Training
Required Skills
Market Research
Marketing
Requirements
  • Bachelor’s degree with a preference for an advanced degree in business or sciences
  • 10+ years of experience in the pharmaceutical/biotech industry
  • 3+ years pharmaceutical/biotech industry commercial training role
  • Leadership experience, specifically in managing the identification and development of commercial resources to solve business challenges
  • Experience in adult education principles including competency modeling
  • Proven project management, presentation, and interpersonal (both verbal and written) communication skills
  • Demonstrated ability to work independently and manage projects that require collaboration across functional areas including Marketing, Market Research, Market Access, Medical Affairs, HR, Corporate Compliance, etc.
  • Able to work under pressure, meet tight deadlines, and collaborate across groups
  • Ability to travel domestically and internationally as required
Responsibilities
  • Lead a team of training and development professionals, including identifying and hiring talent to support the growth of their training team
  • Work cross-functionally to develop, deliver and evaluate training programs, curricula and corresponding training materials and programs for field representatives and field leadership
  • Design all relevant training modules and onboarding materials in accordance with Medical, Marketing, Regulatory and Legal guidance
  • Proactively identify training needs and develop effective strategies for deployment to field teams
  • Organize, facilitate and continually improve field team(s) training and orientation, including the roll-out of new materials, messages, and tools
  • Work with Commercial cross-functional teams to plan, design and deliver all training at National Meetings and POAs
  • Develop advanced training curricula for current field team members to improve skills throughout their tenure and meet business goals
  • Proactively conduct on-going communications with field management and other key stakeholders to identify training needs and develop role-specific training objectives and strategies to meet those needs
  • Hold joint responsibility for creating and implementing field organizational development plans
  • Represent Learning and Development in brand and business planning and product launches and/or label expansions
  • Partner with HR team to ensure alignment with company learning and development philosophy
  • Manage the identification and selection of vendors, and subsequent relationships and projects relating to field training
  • Stay abreast of learning, training and development best practices and current trends in pharmaceutical and life science industries - utilizing current advances within digital, live, and virtual platforms
  • Complete ad hoc projects and analyses relating to group responsibilities as requested
Desired Qualifications
  • Preferred experience in cell and genetic therapies, hospital-based selling, and/or hemoglobinopathies
Vertex Pharmaceuticals

Vertex Pharmaceuticals

View

Vertex Pharmaceuticals develops medicines for serious diseases, focusing on conditions like cystic fibrosis. The company conducts extensive research and development to create new drugs, often collaborating with other biotech firms to enhance its therapeutic offerings. One of its notable products is ivacaftor, which has shown effectiveness in treating cystic fibrosis. Vertex differentiates itself from competitors through its commitment to scientific innovation and strategic partnerships that expand its research capabilities. The goal of Vertex Pharmaceuticals is to improve the quality of life for patients with severe and life-threatening conditions by bringing effective treatments to market.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Boston, Massachusetts

Founded

1989

Simplify Jobs

Simplify's Take

What believers are saying

  • Vertex's EU approval expands its cystic fibrosis treatment market.
  • Partnerships with Arbor and Orna enhance Vertex's gene therapy capabilities.
  • Increased rare disease research funding supports Vertex's R&D efforts.

What critics are saying

  • Competition in cystic fibrosis treatments threatens Vertex's market share.
  • High R&D costs and trial delays could strain Vertex's finances.
  • Regulatory challenges may limit Vertex's drug market expansion.

What makes Vertex Pharmaceuticals unique

  • Vertex focuses on transformative medicines for serious diseases, like cystic fibrosis.
  • The company invests heavily in R&D and strategic biotech partnerships.
  • Vertex's innovative cell and gene therapies set it apart in the biotech industry.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Hybrid Work Options

Company News

BioSpace
Apr 14th, 2025
Vertex Researcher, Paul Negulescu Ph.D., Receives the 2025 Canada Gairdner International Award for Pioneering Research and Discovery of Medicines for Cystic Fibrosis

Vertex researcher, Paul Negulescu Ph.D., receives the 2025 Canada Gairdner International Award for pioneering Research and discovery of medicines for Cystic Fibrosis.

Biz Owner Daily
Apr 7th, 2025
EU Approves Expanded Label for Vertex Pharmaceuticals' Cystic Fibrosis Treatment

Vertex Pharmaceuticals has received approval from the European Union to broaden the label for its cystic fibrosis treatment.

Slater Sentinel
Mar 23rd, 2025
Stevens Capital Management LP Makes New $829,000 Investment in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)

Stevens Capital Management LP makes new $829,000 investment in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX).

Investing.com
Mar 20th, 2025
BMO maintains Vertex stock Market Perform rating and $41 target

The reaffirmation of the rating and target came after Vertex held its first analyst day since its initial public offering in 2020.

Stat News
Mar 18th, 2025
Genetics expert is first NIH director to leave under Trump

He will be replaced on an interim basis by Director Ian Smith, a former Vertex Pharmaceuticals executive.